Keywords: cephalon, acquire, anesta, 444m, deal, biotechnology, company

Cephalon to acquire Anesta in $444M deal

Article | 18 July 2000

Print This

US biotechnology company Cephalon has said it plans to merge with AnestaCorp to create a stronger, more profitable pharmaceutical business. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in